Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 5/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 1.00 |
| ▸ | HTR1A | P08908 | 4/20 | 1.00 |
| ▸ | CYP2C8 | P10632 | 4/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | CYP2E1 | P05181 | 2/20 | 1.00 |
| ▸ | CYP2A6 | P11509 | 2/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | MTOR | P42345 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Shogaol SCHEMBL10523393 | 1.00 | LTA4H (1.00) | LTA4HCYP1A2CYP3A4TRPV1HTR1A | |
| Shogaol SCHEMBL29423038 | 1.00 | LTA4H (1.00) | LTA4HCYP1A2CYP3A4TRPV1HTR1A | |
| Shogaol SCHEMBL29711754 | 1.00 | LTA4H (1.00) | LTA4HCYP1A2CYP3A4TRPV1HTR1A | |
| Shogaol SCHEMBL29475328 | 1.00 | LTA4H (1.00) | LTA4HCYP1A2CYP3A4TRPV1HTR1A | |
| Shogaol SCHEMBL49054 | 1.00 | LTA4H (1.00) | LTA4HCYP1A2CYP3A4TRPV1HTR1A | |
| SCHEMBL4885150 | 0.99 | HTR1A (1.00) | LTA4HCYP1A2CYP3A4TRPV1HTR1A | |
| SCHEMBL4886648 | 0.99 | HTR1A (1.00) | LTA4HCYP1A2CYP3A4TRPV1HTR1A | |
| SCHEMBL4886657 | 0.99 | HTR1A (1.00) | LTA4HCYP1A2CYP3A4TRPV1HTR1A | |
| SCHEMBL4885163 | 0.99 | HTR1A (1.00) | LTA4HCYP1A2CYP3A4TRPV1HTR1A | |
| SCHEMBL29929375 | 0.99 | HTR1A (1.00) | LTA4HCYP1A2CYP3A4TRPV1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 757 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144780-A1 | COMPOSITION FOR ENHANCING ADRENOMEDULLIN GENE EXPRESSION | HOUSE WELLNESS FOODS CORPORATION (JP) | 2026-05-28 | — | — | US | claimed |
| WO-2026043428-A1 | METHOD OF PREPARING GINGER EXTRACT, COMPOSITION COMPRISING SAID GINGER EXTRACT AND USE THEREOF | CHULABHORN FOUNDATION (TH) | 2026-02-26 | — | — | WO | claimed |
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | claimed |
| WO-2025202300-A1 | COMPLEX COACERVATES FOR NUTRACEUTICALS | NEKTIUM PHARMA S.L. (ES) | 2025-10-02 | — | — | WO | claimed |
| EP-4623703-A1 | COMPLEX COACERVATES FOR NUTRACEUTICALS | Nektium Pharma S.L. (ES) | 2025-10-01 | — | — | EP | claimed |
| US-20250295668-A1 | METHODS FOR INDUCING COLANIC ACID BIOSYNTHESIS | HOWARD HUGHES MEDICAL INSTITUTE (US) | 2025-09-25 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-4599698-A1 | PRODUCTS COMPRISING SENSORY AGENTS | Nicoventures Trading Limited (GB) | 2025-08-13 | — | — | EP | claimed |
| EP-4593977-A1 | PRODUCTS AND METHODS RELATED TO THE DISTILLATION OF MOLECULES FROM AEROSOLS | Natural Extraction Systems, LLC (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4588470-A1 | PHARMACEUTICAL COMPOSITION COMPRISING CURCUMIN AND THE PREPARATION THEREOF | Löffler, Bernd-Michael (DE) | 2025-07-23 | — | — | EP | claimed |
| CN-106659789-A | Cyp2j2 antagonists in the treatment of pain | 弗劳恩霍夫应用研究促进协会 | 2017-05-10 | — | — | CN | claimed |
| CN-106645450-A | Quality detection method for novel biological particle | 南京中医药大学 | 2017-05-10 | — | — | CN | claimed |
| CN-106474383-A | A kind of pharmaceutical composition treating acute bronchitiss | 河南水晶头文化传媒有限公司 | 2017-03-08 | — | — | CN | claimed |
| CN-105491894-A | Agent for imparting alcoholic feeling | HASEGAWA T CO LTD | 2016-04-13 | — | — | CN | claimed |
| CN-105007947-A | Solid solution compositions and their use in cardiovascular disease | BIOCOPEA LTD | 2015-10-28 | — | — | CN | claimed |
| CN-104981253-A | Solid solution compositions and use in chronic inflammation | BIOCOPEA LTD | 2015-10-14 | — | — | CN | claimed |
| CN-104968368-A | Solid solution compositions and their use in severe pain | INFIRST HEALTHCARE LTD | 2015-10-07 | — | — | CN | claimed |
| CN-103391768-A | Compostions and methods for treating chronic inflammation and inflammatory diseases | BIOCOPEA LTD | 2013-11-13 | — | — | CN | claimed |
| CN-103391767-A | Compositions and methods for treating cardiovascular disease | BIOCOPEA LTD | 2013-11-13 | — | — | CN | claimed |
| CN-102266547-B | Preparation method of ginger extract with detoxifying effect on exogenous carcinogens and product | UNIV NANJING FINANCE & ECO | 2013-06-12 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144780-A1 | COMPOSITION FOR ENHANCING ADRENOMEDULLIN GENE EXPRESSION | TRPA1, TRPV1, TRPM6 | LTA4H 1137/4885CYP1A2 2094/4885CYP3A4 2359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.